Suresh G Joshi

Prof. Dr. Suresh G Joshi

Drexel University, School of Biomedical Engr, Science & Health Systems, and Microbiology Immunology, and Dermatology, and Surgery, Philadelphia, PA 19104, USA
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2011 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
Suresh G JoshiSuresh G Joshi
Suresh G Joshi
MCMoogega Cooper
Moogega Cooper
AYAdam Yost
Adam Yost
MPMichelle Paff
Michelle Paff
UEUtku K. Ercan
Utku K. Ercan
ABAri D. Brooks
Ari D. Brooks
Oxidative stress leads to membrane lipid peroxidation, which yields products causing variable degrees of detrimental oxidative modifications in cells. Reactive oxygen species (ROS) are the key regulators in this process and induce lipid peroxidation in Escherichia coli . Application of nonthermal (cold) plasma is increasingly used for inactivation of surface contaminants. Recently, we reported a successful application of nonthermal plasma, using a floating-electrode dielectric-barrier discharge (FE-DBD) technique for rapid inactivation of bacterial contaminants in normal atmospheric air (S. G. Joshi et al., Am. J. Infect. Control 38:293-301, 2010). In the present report, we demonstrate that FE-DBD plasma-mediated inactivation involves membrane lipid peroxidation in E. coli . Dose-dependent ROS, such as singlet oxygen and hydrogen peroxide-like species generated during plasma-induced oxidative stress, were responsible for membrane lipid peroxidation, and ROS scavengers, such as α-tocopherol (vitamin E), were able to significantly inhibit the extent of lipid peroxidation and oxidative DNA damage. These findings indicate that this is a major mechanism involved in FE-DBD plasma-mediated inactivation of bacteria.

10 May 2021 in Journal of Applied Microbiology
Verified
Journal Article
Open access
PDF file
MNMarie Nguyen
Marie Nguyen
Suresh G JoshiSuresh G Joshi
Suresh G Joshi
Carbapenem is an important therapy for serious hospital‐acquired infections and for the care of patients affected by multidrug‐resistant organisms, specifically Acinetobacter baumannii; however, with the global increase of carbapenem‐resistant Ac. baumannii, this pathogen has significantly threatened public health. Thus, there is a pressing need to better understand this pathogen in order to develop novel treatments and control strategies for dealing with Ac. baumannii. In this review, we discuss an overview of carbapenem, including its discovery, development, classification and biological characteristics, and its importance in hospital medicine especially in critical‐care units. We also describe the peculiarity of bacterial pathogen, Ac. baumannii, including its commonly reported virulence factors, environmental persistence and carbapenem resistance mechanisms. In closing, we discuss various control strategies for overcoming carbapenem resistance in hospitals and for limiting outbreaks. With the appearance of strains that resist carbapenem, the aim of this review is to highlight the importance of understanding this increasingly problematic healthcare‐associated pathogen that creates significant concern in the field of nosocomial infections and overall public health.

1 May 2010 in American Journal of Infection Control
Verified
Journal Article
Closed access
Suresh G JoshiSuresh G Joshi
Suresh G Joshi
MPMichelle Paff
Michelle Paff
GFGary Friedman
Gary Friedman
GFGreg Fridman
Greg Fridman
AFAlexander Fridman
Alexander Fridman
ABAri D. Brooks
Ari D. Brooks

23 February 2024 in Pathogens
Verified
Journal Article
Open access
PDF file
KZKira M. Zack
Kira M. Zack
TSTrent Sorenson
Trent Sorenson
Suresh G JoshiSuresh G Joshi
Suresh G Joshi
Bacteria express a plethora of efflux pumps that can transport structurally varied molecules, including antimicrobial agents and antibiotics, out of cells. Thus, efflux pump systems participate in lowering intracellular concentrations of antibiotics, which allows phenotypic multidrug-resistant (MDR) bacteria to survive effectively amid higher concentrations of antibiotics. Acinetobacter baumannii is one of the classic examples of pathogens that can carry multiple efflux pump systems, which allows these bacteria to be MDR-to-pan-drug resistant and is now considered a public health threat. Therefore, efflux pumps in A. baumannii have gained major attention worldwide, and there has been increased interest in studying their mechanism of action, substrates, and potential efflux pump inhibitors (EPIs). Efflux pump inhibitors are molecules that can inhibit efflux pumps, rendering pathogens susceptible to antimicrobial agents, and are thus considered potential therapeutic agents for use in conjunction with antibiotics. This review focuses on the types of various efflux pumps detected in A. baumannii, their molecular mechanisms of action, the substrates they transport, and the challenges in developing EPIs that can be clinically useful in reference to A. baumannii.

1 March 2014 in JAMA Dermatology
Verified
Journal Article
Closed access
PDF file
HAHerbert B. Allen
Herbert B. Allen
NVNachiket D. Vaze
Nachiket D. Vaze
CCCatherine Choi
Catherine Choi
THTesfu Hailu
Tesfu Hailu
BTBrittain H. Tulbert
Brittain H. Tulbert
Suresh G JoshiSuresh G Joshi
Suresh G Joshi
Research from JAMA Dermatology — The Presence and Impact of Biofilm-Producing Staphylococci in Atopic Dermatitis

1 February 2014 in Journal of Medical Microbiology
Verified
Journal Article
Open access
MNMichael Neidrauer
Michael Neidrauer
UEUtku K. Ercan
Utku K. Ercan
ABAparna Bhattacharyya
Aparna Bhattacharyya
JSJoshua Samuels
Joshua Samuels
JSJason Sedlak
Jason Sedlak
Suresh G JoshiSuresh G Joshi
Suresh G Joshi
Topical delivery of nitric oxide (NO) through a wound dressing has the potential to reduce wound infections and improve healing of acute and chronic wounds. This study characterized the antibacterial efficacy of an ointment containing NO-loaded, zinc-exchanged zeolite A that releases NO upon contact with water. The release rate of NO from the ointment was measured using a chemiluminescence detection system. Minimum bactericidal concentration assays were performed using five common wound pathogens, including Gram-negative bacteria (Escherichia coli and Acinetobacter baumannii), Gram-positive bacteria (Staphylococcus epidermidis and meticillin-resistant Staphylococcus aureus) and a fungus (Candida albicans). The time dependence of antimicrobial activity was characterized by performing log-reduction assays at four time points after 1–8 h ointment exposure. The cytotoxicity of the ointment after 24 h was assessed using cultured 3T3 fibroblast cells. Minimum microbicidal concentrations (MMCs) for bacterial organisms (5×107 c.f.u.) ranged from 50 to 100 mg ointment (ml media)−1; the MMC for C. albicans (5×104 c.f.u.) was 50 mg ointment (ml media)−1. Five to eight log reductions in bacterial viability and three log reductions in fungal viability were observed after 8 h exposure to NO–zeolite ointment compared with untreated organisms. Fibroblasts remained viable after 24 h exposure to the same concentration of NO–zeolite ointment as was used in antimicrobial tests. In parallel studies, full-thickness cutaneous wounds on Zucker obese rats healed faster than wounds treated with a control ointment. These data indicate that ointment containing NO-loaded zeolites could potentially be used as a broad-spectrum antimicrobial wound-healing dressing.